APPBP2, Amyloid Beta Precursor Protein Binding Protein 2, holds a crucial position in the regulatory network within cells, influencing microtubule dynamics, protein trafficking, and possibly the pathogenesis pathways related to neurodegenerative diseases. Its association with the amyloid precursor protein (APP) hints at a significant yet complex role in cellular signaling pathways and neuronal function. Beyond its interaction with APP, APPBP2 is pivotal in maintaining cellular structure integrity and ensuring the accurate delivery and localization of proteins. By engaging in the stabilization of microtubules and interacting with various proteins, APPBP2 facilitates a range of cellular processes essential for proper cell function and survival. The broad spectrum of its activity underscores the impact of its inhibition on cellular physiology and disease states.
Inhibition of APPBP2 disrupts the fine balance of cellular processes it supports, leading to altered microtubule dynamics, impaired intracellular trafficking, and dysregulated protein synthesis. Mechanistically, the inhibition of APPBP2 could occur through direct interaction with inhibitory molecules that block its binding sites or interfere with its ability to interact with its partners, including APP and components of the microtubule network. Additionally, post-translational modifications that negatively affect APPBP2's function or stability, such as phosphorylation, acetylation, or ubiquitination, could serve as regulatory checkpoints for its inhibition. These modifications might prevent APPBP2 from adopting conformations necessary for its activity or facilitate its degradation. Moreover, the cellular localization of APPBP2 could be influenced by signaling pathways that sequester the protein away from its sites of action, effectively inhibiting its function. Understanding the mechanisms by which APPBP2 activity is inhibited can reveal critical insights into the regulation of cellular processes it is involved in and highlight targets for exploring the pathophysiology of diseases where APPBP2's function is implicated. The intricate balance of activation and inhibition of such regulatory proteins exemplifies the complexity of cellular homeostasis and the nuanced control mechanisms that maintain cellular function and health.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $280.00 | 1 | |
MLN4924 is one of the most well-known APPBP2 inhibitors and has been extensively studied trials for its potential anticancer properties. It disrupts the neddylation process, leading to the inhibition of Cullin-RING E3 ligases and subsequent cell cycle arrest and apoptosis. | ||||||
MLN7243 | 1450833-55-2 | sc-507338 | 5 mg | $340.00 | ||
TAK-243 is a potent APPBP2 inhibitor with potential antitumor activity. Like MLN4924, it disrupts neddylation and inhibits the activity of Cullin-RING E3 ligases. | ||||||